Yahoo India Web Search

Search results

  1. Mark Carter. Group Leader, Stem Cell Biology at Minerva Biotechnologies. Show contact. Mark Carter has a long and varied work history, beginning in 1991 when they were a Clinical Laboratory Technician and Computer Systems Manager at Brigham and Women's Hospital.

  2. Mark G. Carter, PhD. Group Leader, Stem Cell Biology at Minerva Biotechnologies. Linkedin Profile.

    • Group Leader, Stem Cell Biology
    • Minerva Biotechnologies
  3. Mar 1, 2011 · View Mark Carter’s profile on LinkedIn, a professional community of 1 billion members.

    • 155
    • 155
    • Minerva Biotechnologies
  4. Mark G. Carter's 19 research works with 25 citations and 478 reads, including: Abstract 1148: 1XX mutations slow CAR T cell signaling and increase in vivo persistence.

  5. Mar 7, 2013 · We report that a single growth factor, NM23-H1, enables serial passaging of both human ES and iPS cells in the absence of feeder cells, their conditioned media or bFGF in a fully defined xeno-free media on a novel defined, xeno-free surface.

    • Benoit J. Smagghe, Andrew K. Stewart, Mark G. Carter, Laura M. Shelton, Kyle J. Bernier, Eric J. Har...
    • 2013
  6. Toshio Hamatani, Mark G. Carter, Alexei A. Sharov, Minoru S.H. Ko. Research output: Contribution to journal › Article › peer-review. 734 Citations (Scopus) Overview. Fingerprint. Abstract.

  7. Mark G Carter's 10 research works with 219 citations and 1,208 reads, including: Jak/Stat3 Signaling Promotes Somatic Cell Reprogramming by Epigenetic Regulation